Trial intelligence / Profile preview

Interferon Gamma-1b in Idiopathic Pulmonary Fibrosis

NCT00047658Phase 2Completed

Sponsor
InterMune
Start
Nov 2001
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of interferon gamma-1b in idiopathic pulmonary fibrosis (IPF), sponsored by InterMune. Started Nov 2001; status: completed.

02

Drugs

interferon gamma-1b
03

Conditions

idiopathic pulmonary fibrosis (IPF)

Beyond the preview

Go deeper on NCT00047658.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00047658.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call